Learn more

UNIV COLUMBIA CITY NEW YORK

Overview
  • Total Patents
    61
About

UNIV COLUMBIA CITY NEW YORK has a total of 61 patent applications. Its first patent ever was published in 1983. It filed its patents most often in Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UMC UTRECHT HOLDING BV, UNIV LELAND STANFORD JUNIOR and MAYO FOUNDATION.

Patent filings in countries

World map showing UNIV COLUMBIA CITY NEW YORKs patent filings in countries
# Country Total Patents
#1 Australia 61

Patent filings per year

Chart showing UNIV COLUMBIA CITY NEW YORKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Fisher Paul B 7
#2 Stern David 4
#3 Erlanger Bernard F 4
#4 Schmidt Ann Marie 3
#5 Sposili Robert S 2
#6 Su Zao-Zhong 2
#7 Im James S 2
#8 Crowder Mark A 2
#9 Dalla-Favera Riccardo 2
#10 Pinsky David J 2

Latest patents

Publication Filing date Title
AU2584201A Progressive elevated gene-3 (peg-3) induces aggressive cancer phenotype and regulates angiogenesis
AU2048901A Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
AU7716900A Hcv e2 protein binding agents for treatment of hepatitis c virus infection
AU5468400A Gene encoding nade, P75ntr-associated cell death executor and uses thereof
AU2493499A Determination of the amount of hlhbeta core fragment in a sample from a subject and uses thereof
AU2492699A Electrical system for weight loss and laparoscopic implantation thereof
AU9310298A T-independent conjugate-vaccines
AU8265598A Method and apparatus for circulatory valve repair
AU8162898A Angiogenic modulation by notch signal transduction
AU7688998A Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU4367096A Unique associated kaposi's sarcoma virus sequences and uses thereof
AU4958590A Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof